Antibody Discovered To Boost HIV Vaccines
An anonymous reader sends this clip from Scienceblog.com. "Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat. ... Research efforts to find individual antibodies that can neutralize HIV strains have been difficult because the virus continuously changes its surface proteins to evade recognition by the immune system. As a consequence of these changes, an enormous number of HIV variants exist worldwide. However, there are a few surface areas that remain nearly constant across all variants of HIV and scientists have now discovered two potent human antibodies that attach to one of these sites and can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory. ... The researchers also confirmed that VRC01 does not bind to human cells — a characteristic that might otherwise lead to its elimination during immune development, a natural mechanism the body employs to prevent autoimmune disease."
But I have to wonder if the region that doesn't normally morph will start morphing if it starts being targetted. HIV is a tough little bugger. Very borg-like.
It is unwise to ascribe motive
It won#t start suddenly morphing. What will happen, is that the strain which DO morph will be selected for, as they will more easily spread, than the one stopped by this antibody. But I would not put my hope too high. "In laboratory" means in-vitro. A lot of stuff works in vitro, but never pan out.
C. Sagan : A demon haunted world:
http://www.amazon.com/gp/product/0345409469/
visit randi.org
I understand this is a great achievement in preventing the spread of the disease, but won't the long-term effect just be that the 10% of the virus that's unaffected becomes 100% of what's spreading?
Yes, that explains why AIDS treatments have been getting better and cheaper.
The Kruger Dunning explains most post on
I fail to see the hype. There are plenty of great anti-HIV antibodies which are well described. These have a great cross-reactivity to many HIV strains and are directed against very conserved regions of envelope proteins. The trouble lies that no one so far has been able to find a way to produce them in a patient's body in large amounts. In addition, it is well known that Ab response is not really the way to go. Current HIV vaccines designs are moving towards inducing a innate immunity responses and also focus on T-cell not B-cell mediated immunity.